期刊文献+

中国医药制造业财务风险的实证分析和控制措施 被引量:5

Empirical Analysis of Financial Risk for Chinese Pharmaceutical Industry and Conformity Measure
原文传递
导出
摘要 中国医药市场的特点表现为:市场竞争激烈,市场集中度不断提高,药品价格逐步下降,医药产业的子行业,面临的市场环境各不相同。在这样的市场环境下,医药企业如何避免陷入财务危机,控制财务风险是企业发展面临的重要问题之一。Z值模型是评估企业财务风险的经典方法之一,主要特点是客观准确,计算简便,具有较强的操作性。医药企业可通过提高主营业务收入,开发企业拳头产品等措施来控制企业财务风险。 There are several characteristics of Chinese pharmaceutical market: fierce competitive, rising market concentration, falling drug price. Besides, different sub-sectors of pharmaceutical industry are under various kinds of market environment. In such cases, in order to get development, it is important for pharmaceutical enterprises to try to avoid from being in trouble in financial collapse, and lower financial risk. Z-Value Model is objective, accurate, simply calculating and easily operative, and has been widely used to evaluate financial risk. Pharmaceutical enterprises can improve prime operating revenue, develop hit product and take other actions to control financial risk.
作者 梁谋 卞鹰
出处 《企业活力》 2010年第5期10-13,共4页 Enterprise Vitality
关键词 医药制造业 Z值模型 财务风险 pharmaceutical industry Z-value model financial risk
  • 相关文献

参考文献9

二级参考文献27

共引文献161

同被引文献24

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部